A clinical study to evaluate the effciency of indigenous Avaleha formulation in the management of Rajonivrutti lakshnas w.s.r to post menopausal syndrome.

A clinical study to evaluate the efficacy of indigenous Avaleha formulation in the management of Rajonivrutti lakshnas w.s.r to post menopausal syndrome. - Rajonivrutti Lakshana Menopause

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/10/021722

Enrollment

Registered

2019-10-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N951- Menopausal and female climactericstates

Interventions

Intervention1: Avaleha in Post Menopausal women: Dose 24gms twice daily before food with milk 1 month follow up 1 month Control Intervention1: Not applicable: NA

Eligibility

Inclusion criteria

Inclusion criteria: Back ache vaginal dryness hot flushes excessive sweating headache mood swings depression sleep disturbance

Exclusion criteria

Exclusion criteria: pre mature menopause(before 40 years) any pre-exisiting psychological disorders delayed menopause diabetes mellitus surgical menopause disc problem any systemic disorders

Design outcomes

Primary

Measure	Time frame
improvement in symptoms clinical features of post menopausal syndromeTimepoint: 3 month	—

Secondary

Measure	Time frame
improvement in general health improvement in symptomsTimepoint: after clinical trial period	—

Countries

India

Contacts

Public ContactDr Rita makim

Parul Institue of Ayurveda

ritamakim@gmail.com9427538404

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026